Thank you to the witnesses who are here today in front of the science and research committee.
Mr. Linke, Canada positions itself as a leader in AI, yet we remain behind our peers in launching new antibiotics.
From your vantage point, what are specific AI-enabled opportunities that Canada is failing to capitalize on right now with respect to antibiotics?